Is AnswerThis profitable?

AnswerThis describes itself as cash-flow positive in job postings dated March 16, 2026, and claims $1.5M+ ARR (self-reported, unaudited). No independent financial audit or press confirmation of these figures has been found as of mid-2026.

AnswerThis is a privately held, venture-backed startup founded in 2024 by CEO/CTO Ayush Garg and CMO Ryan McCarroll. It is part of Y Combinator's Fall 2025 batch; no independently verified priced funding round beyond YC's standard investment has been confirmed as of 2026.

Could AI replace AnswerThis?

Yes, largely. AnswerThis's core search-summarize-cite workflow over public papers is the same feature frontier labs are shipping natively: ChatGPT Deep Research, Claude Projects, Google NotebookLM/Gemini, and Perplexity Pro all added academic-research modes on a monthly-to-quarterly cadence through mid-2026.

Who is AnswerThis's biggest competitor?

Specialist rivals Elicit (PRISMA 2020 compliant as of May 2026, self-reported) and Consensus (added 'Deep Search' in 2025) compete directly on literature review, while OpenAI, Anthropic, Google, and Perplexity are adding overlapping research-agent features as of 2026.

Has AnswerThis raised venture funding?

A third-party review cites a $500K seed round in 2025, matching YC's standard batch investment, but this is an aggregator estimate without a primary press release; no confirmed priced round, valuation, or lead investor for AnswerThis was found as of mid-2026.

What is AnswerThis pivoting toward?

By March 2026, job postings show AnswerThis shifting messaging toward becoming a 'system of record for scientists,' targeting Fortune 500 and life-sciences customers and building AI agent orchestration, graph RAG, and vector-DB memory, away from its original public-paper search tool.

YC Fall 2025 · United States

AnswerThis

AI assistant that searches, summarizes, and cites academic papers for researchers.

Losing its protection

Assessed 27 July 2026 · Evidence as of 27 July 2026

The structural protection is eroding.

On the recordSince 27 July 2026 · Checkable from Q4 2026 · Every call on the record Checkpoint: 18 month runway window to land named enterprise pharma contracts with SOC2/GxP compliance

The call

AnswerThis has early traction over public paper search, a space frontier AI labs are entering directly, with an unproven pivot to proprietary lab data as its main open path.

AnswerThis lets researchers search public scientific papers, get summaries, and see citations. The problem is that OpenAI, Google, Anthropic, and other large AI labs are building the same feature into their own products every few months, and specialized competitors like Elicit and Consensus already focus on this exact use case. The company's only real chance is to move fast into helping pharmaceutical and biotech companies organize and search their own private research data instead of just public papers, before the big labs and entrenched players like Benchling and Veeva move there first.

Why

AI pressure: OpenAI ChatGPT Deep Research, Anthropic Claude Projects, Google NotebookLM, Perplexity Pro. Frontier labs now ship native deep research modes over the same public papers, aimed at the exact task AnswerThis charges $21 a month for. Could AI do the core job? Yes, likely.

Bigger players: Benchling, Veeva. Benchling and Veeva already own pharma lab data workflows and could bolt on AI search before AnswerThis locks in enterprise deals. Could a giant copy it? Yes, easily.

What protects it. Early revenue and a large free user base show real demand, but nothing stops users from switching to a bigger AI tool's free research mode.

What would change this call

AnswerThis announces named pharma or biotech design-partner contracts by Q4 2026. Would show the enterprise lab-data pivot is real, not just consumer subs.
OpenAI, Google, or Perplexity fold deep academic-search modes into their free or base subscription tier. Would commoditize AnswerThis's $21/mo consumer product on public papers.
AnswerThis announces a priced Series A with a named lead investor before its 18-month runway ends. Would confirm self-reported ARR and cash-flow claims convinced outside investors.

Key numbers

$1.5M+ ARR self-reported (2026-03-16)
200K-250K+ researchers claimed on platform (2025-10-31)
Searches 250-300M+ academic papers (2025-10-31)

Named risks

Core product is an LLM wrapper over public paper corpora with no proprietary data or licensing moat shipped. Severity: high
Enterprise/life-sciences pivot to 'system of record' is unproven with no verified named contracts as of March 2026. Severity: high
Seed funding environment down 27% YoY (Q2 2026) with ~9% seed-to-A conversion threatens next raise. Severity: medium
All traction and revenue figures (ARR, user counts) are self-reported and unaudited. Severity: medium
Category-wide citation-accuracy failures seen at competitor SciSpace pose reputational risk to AI research tools generally. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Elicit	losing to	Elicit reportedly reached PRISMA 2020 compliance for systematic reviews by May 2026
Consensus	losing to	Consensus shipped full-paper 'Deep Search' with gap-flagging in 2025
OpenAI, Anthropic, Google, Perplexity	losing to	Frontier labs ship native academic deep-research modes on monthly-quarterly cadence through 2026
Benchling, Veeva	contesting	AnswerThis's 2026 enterprise/lab-data pivot targets workflows these incumbents already own
Elsevier (Scopus AI)	contesting	Elsevier launched Scopus AI (Jan 2024) covering similar paper-navigation ground

Questions people ask

Is AnswerThis profitable?: AnswerThis describes itself as cash-flow positive in job postings dated March 16, 2026, and claims $1.5M+ ARR (self-reported, unaudited). No independent financial audit or press confirmation of these figures has been found as of mid-2026.
Who owns AnswerThis?: AnswerThis is a privately held, venture-backed startup founded in 2024 by CEO/CTO Ayush Garg and CMO Ryan McCarroll. It is part of Y Combinator's Fall 2025 batch; no independently verified priced funding round beyond YC's standard investment has been confirmed as of 2026.
Could AI replace AnswerThis?: Yes, largely. AnswerThis's core search-summarize-cite workflow over public papers is the same feature frontier labs are shipping natively: ChatGPT Deep Research, Claude Projects, Google NotebookLM/Gemini, and Perplexity Pro all added academic-research modes on a monthly-to-quarterly cadence through mid-2026.
Who is AnswerThis's biggest competitor?: Specialist rivals Elicit (PRISMA 2020 compliant as of May 2026, self-reported) and Consensus (added 'Deep Search' in 2025) compete directly on literature review, while OpenAI, Anthropic, Google, and Perplexity are adding overlapping research-agent features as of 2026.
Has AnswerThis raised venture funding?: A third-party review cites a $500K seed round in 2025, matching YC's standard batch investment, but this is an aggregator estimate without a primary press release; no confirmed priced round, valuation, or lead investor for AnswerThis was found as of mid-2026.
What is AnswerThis pivoting toward?: By March 2026, job postings show AnswerThis shifting messaging toward becoming a 'system of record for scientists,' targeting Fortune 500 and life-sciences customers and building AI agent orchestration, graph RAG, and vector-DB memory, away from its original public-paper search tool.

Timeline

2026-06-15Competitor Elicit reportedly becomes PRISMA 2020 compliant, raising the literature-review bar
2026-03-23Pricing reported: free tier plus ~$21/month Premium billed annually, plus Enterprise tier
2026-03-16Job postings cite $1.5M+ ARR, cash-flow positive status, and enterprise/life-sciences pivot messaging
2026-01-02AnswerThis posts AI agent orchestration role signaling pivot to multi-agent research workflows
2025-12-14Third-party review describes a conflicting enterprise-knowledge-base version of AnswerThis
2025-10-31YC Launch: AnswerThis claims 200K-250K+ researchers and 250K+ queries in two months
2024AnswerThis founded, per YC company profile
2023-10-15Ayush Garg posts earlier AnswerThis pitch with a different co-founder, predating 2024 founding

Revision history

27 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Nexus Terrain Metorial